Chemoinformaics analysis of Methyl heptadecanoate
| Molecular Weight | 284.484 | nRot | 15 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 1 |
| Exact Molecular Weight | 284.272 | nRing | 0 |
| Solubility: LogS | -6.808 | nHRing | 0 |
| Solubility: LogP | 7.623 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 55.6685 |
| nHD | 0 | BPOL | 38.7195 |
| QED | 0.271 |
| Synth | 1.768 |
| Natural Product Likeliness | 0.241 |
| NR-PPAR-gamma | 0.13 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.818 |
| MDCK | 0.000015 |
| BBB | 0.267 |
| PPB | 0.972865 |
| VDSS | 2.345 |
| FU | 0.0146173 |
| CYP1A2-inh | 0.442 |
| CYP1A2-sub | 0.201 |
| CYP2c19-inh | 0.423 |
| CYP2c19-sub | 0.078 |
| CYP2c9-inh | 0.18 |
| CYP2c9-sub | 0.945 |
| CYP2d6-inh | 0.165 |
| CYP2d6-sub | 0.058 |
| CYP3a4-inh | 0.357 |
| CYP3a4-sub | 0.058 |
| CL | 4.864 |
| T12 | 0.237 |
| hERG | 0.269 |
| Ames | 0.006 |
| ROA | 0.024 |
| SkinSen | 0.957 |
| Carcinogencity | 0.056 |
| EI | 0.968 |
| Respiratory | 0.907 |
| NR-Aromatase | 0.037 |
| Antiviral | Yes |
| Prediction | 0.573051 |